Show
Sort by
-
Epcoritamab with rituximab plus lenalidomide (R2) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7
-
CARTITUDE-2 cohort B : efficacy and safety of ciltacabtagene autoleucel, a chimeric antigen receptor T-cell therapy directed against B-cell maturation antigen, in patients with multiple myeloma and early relapse after initial treatment
(2022) BRITISH JOURNAL OF HAEMATOLOGY. In British Journal of Haematology 197(supplement 1). p.118-119 -
- Journal Article
- A1
- open access
Agriculture intensifies soil moisture decline in Northern China